Patent Assignment
Reel/Frame 058247/0761
Assignment of Assignor's Interest
Recorded: 2021-11-30
Pages: 13
Assignee
INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, 37TH FLOOR, NEW YORK, NEW YORK, 10001
Covered Properties
(3)
Pharmaceutical Compositions for Combination Therapy
PCT:
PCT/US2020/035353 ↗
Pharmaceutical Compositions Comprising a Fxr Agonist and a Fibrate for Use in the Treatment of Cholestatic Liver Disease
Application:
17/615,186 →
Publication:
US 2022/0226350
Pharmaceutical Compositions for Combination Therapy
Application:
62/854,859 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Apr 27, 2022
From: INTERCEPT PHARMACEUTICALS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 059749/0019 →
Change of Address
Aug 22, 2022
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 061297/0990 →
Release of Security Interest
Jan 4, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 066662/0210 →
Assignment of Assignor's Interest
Mar 12, 2026
From: INTERCEPT PHARMACEUTICALS, INC.
To: ALFASIGMA S.P.A
Reel/Frame 075044/0679 →